Determination of solifenacin in human plasma by liquid chromatography-tandem mass spectrometry
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
21071290
DOI
10.1016/j.jchromb.2010.10.010
PII: S1570-0232(10)00644-6
Knihovny.cz E-zdroje
- MeSH
- chinuklidiny krev chemie farmakokinetika MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- lineární modely MeSH
- reprodukovatelnost výsledků MeSH
- senzitivita a specificita MeSH
- solifenacin sukcinát MeSH
- stabilita léku MeSH
- tandemová hmotnostní spektrometrie metody MeSH
- tetrahydroisochinoliny krev chemie farmakokinetika MeSH
- vysokoúčinná kapalinová chromatografie metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- chinuklidiny MeSH
- solifenacin sukcinát MeSH
- tetrahydroisochinoliny MeSH
A liquid chromatography-electrospray tandem mass spectrometry method was developed and validated to quantitate solifenacin in human plasma. The assay was based on protein precipitation with methanol and liquid chromatography performed on a pentafluorophenylpropylsilica column (50×4mm, 3μm particles), the mobile phase consisted of methanol - 100mM ammonium acetate containing 1% of formic acid (90:10, v/v). Quantification was through positive-ion mode and selected reaction monitoring at m/z 363→193 and 368→198 for solifenacin and the internal standard solifenacin-D(5), respectively. The lower limit of quantitation was 0.47ng/ml using 0.25ml of plasma and linearity was demonstrated up to 42ng/ml. Intra-assay and inter-assay precision expressed by relative standard deviation was less than 11% and inaccuracy did not exceed 11% at all levels. The assay was applied to the analysis of samples from a pharmacokinetic study.
Citace poskytuje Crossref.org